Search Result "AD"
Immunotherapeutics for AD: A Work in Progress
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 21 Issue: 9 Year: 2022 Page: 752-765
Author(s): Yatender Kumar,Jaspreet Singh Anand
Roles of Microglia in AD Pathology
Journal: Current Alzheimer Research
Volume: 19 Issue: 13 Year: 2022 Page: 854-869
Author(s):
Visuospatial Memory in Healthy Elderly, AD and MCI: A Review
Journal: Current Aging Science
Volume: 2 Issue: 1 Year: 2009 Page: 43-59
Author(s): Tina Iachini, Alessandro Iavarone, Vincenzo Paolo Senese, Francesco Ruotolo, Gennaro Ruggiero
Cholesterol, Copper and Aβ in Controls, MCI, AD and the AD Cholesterol- Lowering Treatment Trial (ADCLT)
Journal: Current Alzheimer Research
Volume: 2 Issue: 5 Year: 2005 Page: 527-539
Author(s): D. L. Sparks, Suzana Petanceska, Marwan Sabbagh, Donald Connor, Holly Soares, Charles Adler, Jean Lopez, Chuck Ziolkowski, Jeff Lochhead, Patrick Browne
Zebrafish Experimental Animal Models for AD: A ComprehensiveReview
Journal: Current Reviews in Clinical and Experimental Pharmacology
Volume: 19 Issue: 4 Year: 2024 Page: 295-311
Author(s):
The Impact of AD Drug Treatments on Event-Related Potentials as Markers of Disease Conversion
Journal: Current Alzheimer Research
Volume: 10 Issue: 7 Year: 2013 Page: 732-741
Author(s): Robert M. Chapman,Anton P. Porsteinsson,Margaret N. Gardner,Mark Mapstone,John W. McCrary,Tiffany C. Sandoval,Maria D. Guillily,Lindsey A. Reilly,Elizabeth DeGrush
Volumetric MRI Demonstrates Atrophy of the Olfactory Cortex in AD
Journal: Current Alzheimer Research
Volume: 17 Issue: 10 Year: 2020 Page: 904-915
Author(s): Majed Al-Otaibi,Melissa Lessard-Beaudoin,Christian-Alexandre Castellano,Denis Gris,Stephen C. Cunnane,Rona K. Graham
An Investigation of Industry 4.0 with Client Value Added in the Business Industry
Ebook: Changing Competitive Business Dynamics Through Sustainable Big Data Analysis
Volume: 6 Year: 2024
Author(s): Ravi Kumar Gupta,Debendra Nath Das
Doi: 10.2174/9789815256659124060011
Recent Studies on Design and Development of Drugs Against Alzheimerâs Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 13 Year: 2020 Page: 1195-1213
Author(s): Satya P. Gupta,Vaishali M. Patil
Reduced Risk of Incident AD with Elective Statin Use in a Clinical Trial Cohort
Journal: Current Alzheimer Research
Volume: 5 Issue: 4 Year: 2008 Page: 416-421
Author(s): D. Larry Sparks, Richard J. Kryscio, Marwan N. Sabbagh, Donald J. Connor, Lisa M. Sparks, Carolyn Liebsack